Notably, epithelial to mesenchymal markers (Slug, SUMO2, β-catenin, and E-cadherin) were studied to establish an in-detailed mechanism of action of PYR in both GBM cells (Figure 5C,D). Here, CDH1 is linked to glioblastoma.